FDA Adverse Event Injury Summary report: N

INTERSTIM II

MDR report key: 6615568 · Received June 6, 2017

Report

Report Number
3007566237-2017-02198
Event Type
Injury
Date Received
June 6, 2017
Date of Event
October 6, 2015
Report Date
June 7, 2017
Manufacturer
MEDTRONIC NEUROMODULATION
Product Code
EZW
PMA / PMN Number
P970004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SZ
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE MAIN COMPONENT OF THE SYSTEM, OTHER APPLICABLE COMPONENTS ARE: PRODUCT ID: 3389, PRODUCT TYPE: LEAD. IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

OTHER APPLICABLE COMPONENTS ARE: PRODUCT ID 3889 LOT# UNKNOWN SERIAL# IMPLANTED: EXPLANTED: PRODUCT TYPE LEAD MEDTRONIC, INC. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

INFORMATION WAS RECEIVED FROM A HEALTH CARE PROVIDER (HCP) OF A CLINICAL STUDY VIA A MANUFACTURER REPRESENTATIVE (REP) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR. IT WAS REPORTED THAT THERE WAS A COMPLICATION AS THERE WAS A BROKEN LEAD THAT REQUIRED SURGERY ON (B)(6)2015. NO FURTHER COMPLICATIONS WERE REPORTED/ANTICIPATED.

Description of Event or Problem · 1

INFORMATION WAS RECEIVED FROM A HEALTH CARE PROVIDER (HCP) OF A CLINICAL STUDY VIA A MANUFACTURER REPRESENTATIVE (REP) REGARDING A PATIENT WHO WAS IMPLANTED WITH A NEUROSTIMULATOR. IT WAS REPORTED THAT THERE WAS A COMPLICATION AS THERE WAS A BROKEN LEAD THAT REQUIRED SURGERY ON (B)(6) 2015. NO FURTHER COMPLICATIONS WERE REPORTED/ANTICIPATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
396482 INTERSTIM II STIMULATOR, ELECTRICAL, IMPLANTABLE, FOR INCONTINENCE EZW MEDTRONIC NEUROMODULATION 3058

Patients

Seq Age Sex Outcome Treatment
1 53 YR Required Intervention